The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer questions about the COVID-19 pandemic. The next call is July 9 from 2:30-3:45 p.m. ET. Food and Drug Administration Commissioner Stephen Hahn, M.D., will address FDA’s response to the COVID-19 epidemic, including emergency use authorizations, remdesivir distribution and vaccine clinical trials. 

In addition, AHA Board Chair Melinda Estes, M.D., AHA President and CEO Rick Pollack and AHA senior leaders will give updates on advocacy, regulatory and policy developments, as well as the association’s efforts to support members in their efforts to combat COVID-19. 

Callers are encouraged to dial in at least 10-15 minutes in advance. Please dial 800-469-8538 and enter the participant passcode 43576#.

Related News Articles

Headline
A series of free videos from Med Tac offers guidance on how essential workers and the public can stay safe during the COVID-19 public health emergency.…
Headline
The AHA, American Medical Association, American Society of Health-System Pharmacists, and United States Pharmacopeia last week convened a virtual summit to…
Headline
The National Institutes of Health today announced clinical trials to investigate the safety and efficacy of a synthetic antibody therapy in COVID-19 patients.…
Headline
The Centers for Medicare & Medicaid Services will allow health insurers to offer premium reductions for individuals with 2020 coverage in the individual…
Headline
The Department of Health and Human Services Friday released specifications for reporting certain COVID-19 laboratory data as required by the Coronavirus Aid,…
Headline
The U.S. District Court for the Southern District of New York yesterday ruled against the Department of Labor regarding its regulations related to certain…